rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Alice Lin-Tsing Yu

Director

Company insider

Files Form 4 as: Director, Opko Health.

In numbers

Trades disclosed
30
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
21 Apr 2009
Last trade
18 Jun 2026
Last filed
22 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
OPK Opko HealthDirector · Biotechnology · last 18 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
18 Jun 2026filed 22 Jun 2026OPK Opko Healthoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
18 Jun 2026filed 22 Jun 2026OPK Opko Healthoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
23 Apr 2025filed 23 Apr 2025OPK Opko Healthoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
22 Jun 2023filed 23 Jun 2023OPK Opko Healthoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
14 Jul 2022filed 15 Jul 2022OPK Opko Healthoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
24 Jun 2021filed 25 Jun 2021OPK Opko Healthoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
25 Jun 2020filed 26 Jun 2020OPK Opko Healthoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
20 Jun 2019filed 21 Jun 2019OPK Opko Healthoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
21 Jun 2018filed 22 Jun 2018OPK Opko Healthoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
15 Jun 2017filed 16 Jun 2017OPK Opko Healthoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
10 Apr 2017filed 11 Apr 2017OPK Opko HealthBiotechnologySEC FORM 4 Code M$94K20,000 at $4.72filing
10 Apr 2017filed 11 Apr 2017OPK Opko Healthoption or derivative · BiotechnologySEC FORM 4 Code M—20,000 at $0.00filing
13 Feb 2017filed 12 Mar 2019OPK Opko HealthBiotechnologySEC FORM 4 Code G—13,460 at $0.00filing
5 May 2016filed 5 May 2016OPK Opko Healthoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
5 Feb 2016filed 12 Mar 2019OPK Opko HealthBiotechnologySEC FORM 4 Code G—13,270 at $0.00filing
8 Oct 2015filed 9 Oct 2015OPK Opko HealthBiotechnologySEC FORM 4 Code M$69K20,000 at $3.43filing
8 Oct 2015filed 9 Oct 2015OPK Opko Healthoption or derivative · BiotechnologySEC FORM 4 Code M—20,000 at $0.00filing
18 Aug 2015filed 19 Aug 2015OPK Opko HealthBiotechnologySEC FORM 4 Code M$41K20,000 at $2.05filing
18 Aug 2015filed 19 Aug 2015OPK Opko Healthoption or derivative · BiotechnologySEC FORM 4 Code M—20,000 at $0.00filing
10 Jul 2015filed 12 Mar 2019OPK Opko HealthBiotechnologySEC FORM 4 Code G—6,780 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Adam LogalSr. Vice President, CFO · Sr. Vice President, CFO at Opko Health, filing Form 4 there in the last year
Steven D. RubinDirector · Executive VP-Administration at Opko Health, filing Form 4 there in the last year
Richard C. Pfenniger Jr.Director · Director at Opko Health, filing Form 4 there in the last year
John A. PaganelliDirector · Director at Opko Health, filing Form 4 there in the last year
Prem A. LachmanDirector · Director at Opko Health, filing Form 4 there in the last year